Skip to Content
MilliporeSigma
All Photos(5)

Key Documents

HPA043850

Sigma-Aldrich

Anti-SRSF7 antibody produced in rabbit

enhanced validation

Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution

Synonym(s):

Anti-9G8, Anti-AAG3, Anti-HSSG1, Anti-RBM37, Anti-SFRS7, Anti-Serine/Arginine-Rich Splicing Factor 7, Anti-ZCCHC20, Anti-ZCRB2

Sign Into View Organizational & Contract Pricing
All Photos(5)

About This Item

UNSPSC Code:
12352203
Human Protein Atlas Number:
HPA043850
NACRES:
NA.43
Pricing and availability is not currently available.

biological source

rabbit

Quality Level

100

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

product line

Prestige Antibodies® Powered by Atlas Antibodies

form

buffered aqueous glycerol solution

species reactivity

human

enhanced validation

orthogonal RNAseq
Learn more about Antibody Enhanced Validation

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
EMU081321EMU065881EMU211561
MISSION® esiRNA targeting mouse Uqcrh

EMU094641

MISSION® esiRNA

MISSION® esiRNA targeting mouse Crls1

EMU081321

MISSION® esiRNA

MISSION® esiRNA targeting mouse Uqcr

EMU065881

MISSION® esiRNA

MISSION® esiRNA targeting mouse Cenpm

EMU211561

MISSION® esiRNA

product line

MISSION®

product line

MISSION®

product line

MISSION®

product line

MISSION®

Gene Information

mouse ... UQCRH(66576), Uqcrh(66576)

Gene Information

mouse ... CRLS1(66586), Crls1(66586)

Gene Information

mouse ... Uqcr(66594)

Gene Information

mouse ... CENPM(66570), Cenpm(66570)

Ensembl | mouse accession no.

ENSMUSG00000063882

Ensembl | mouse accession no.

ENSMUSG00000027357

Ensembl | mouse accession no.

ENSMUSG00000020163

Ensembl | mouse accession no.

ENSMUSG00000068101

esiRNA cDNA target sequence

TACTCTGGTTGCGCTTGTTGGATCCCAAACCGGCTCCCGACATGGGACTAGAGGACGAACGAAAGATGCTCACTGGATCTGGAGACCCCAAAGAGGAAGAAGAGGAAGAACTAGTGGACCCCCTAACAACAGTGAGAGAGCACTGTGAACAGCTGGAGAAGTGTGTAAAGGCCCGGGAACGACTAGAGTTGTGTGATAATCGCGTGTCTTCCCGGTCACAGACAGAAGAGGATTGTACAGAGGAGCTCTTTGACTTCTTGCATGCACGGGACCACTGTGTGGCCCACAAGCTCTTTAAAAACTTGAAGTAAATGTGCAGATTCGTCCTCCTCAGCCTTGTCACTGGGAATCAGGAACAGTTCCTTGTGGTTCTGGACGTCGGTGTCTGATGGAGTGAGTTCTCGAGAACCTCACTGACTTTGGCGGTAGCTTC

esiRNA cDNA target sequence

AATCCATGGACAATCCCAAATTTGTTGTCAATGACAAGAATTGGCCTGGCCCCCGTGTTGGGCTACCTGATTCTTGAAGAAGACTTTAATGTTGCACTAGGTGTTTTTGCTTTAGCCGGGCTAACGGATTTGTTGGATGGATTTATTGCTCGAAACTGGGCCAACCAAAAATCAGCTTTGGGAAGTGCTCTTGATCCACTTGCTGATAAAGTTCTTATCAGCATCTTATATATTAGCTTGACCTATGCAGATCTTATTCCAGTCCCACTCACTTACATGATAATTTCAAGAGATGTAATGTTGATCGCTGCTGTGTTTTATGTCAGATACCGAACTCTGCCAACACCGCGAACACTAGCTAAGTACTTCAATCCTTGCTATGCCACGGCTAGGTTAAAACCAACATTCATCAGCAAGGTAAATACAGCAGTCCAGTTAATTTTGGTGGCAGCTTCTTTGGCAGCTCCAGTTT

esiRNA cDNA target sequence

TGCGCTATACGTCTGCACTTGCGTAGTGCTCCAGGGCAGCGGAACGGGGTGACCCTGAGTATTGAGACCCTGCAGCGATGCTGAGCAGGTTTCTAGGCCCGCGCTACCGGGAACTGGCCAGAAACTGGATTCCCACAGCCGGCATGTGGGGCACTGTGGGTGCCGTGGGACTGGTGTGGGCCACGGACTGGCGGCTGATCCTGGACTGGGTGCCTTACATCAACGGCAAGTTTAAGAAGGACGATTAGGCAGCCCCTCCCCCACCACAGGCCTTGATGGTACCATGTGCCGAGGCCTCAGACACAGGGTAGTCCTGTGGAAGACACTGAGGAAGCTGGACACTGGAGAGGTTTGCACCGCTCAGGGAGCTTCCATGTTGACAGACACTAGGGCTGCCTTGATGGGTGCAGCATTAA

esiRNA cDNA target sequence

ACTGCAGGACTGAGCTCCACCAGGGAGGTCTGCTGGGCAGGAGTCGGGAGAGAGCCCAGCGAGACCCCAGCAGCCTCCCGTTTCTCGTCTCACCCCACAGAGGTCCCATCTGCACCTGTCTAACATCATAATCCACCTAAGATTTTGGAACAAAGAGCCATGGCTTTAAAAAAAAAAAAAGAAAGGAAGGAAGGAAATGTGTTGTAGATGCAGAAACTGACTCAGTACAATTGCGGGGGCAAAGTGTGGCTTCCAGGAGCCCAGGGAAAATGTCAGGTCCAGGCCCTGCGTTTCTTACAGCCCGGCTGTTGTATTCTGGTGCCTGTTTTTCCTCGTGTAAGTGGAGCTGGTTCTACTCACATTGAGAGGGCTGAAGGAAATGGCAGGTGGCTTGCTGCCCAAGACCACATTGCTCCCTACAACTTGTTGGTCTCTCTTGTAGATCACACACAGTGTCATGCCTCACACTGTAACAGCAAGCTACCAATCACA

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

form

lyophilized powder

Immunogen

serine/arginine-rich splicing factor 7 recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies® protocols and other useful information.

Features and Benefits

Prestige Antibodies® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:
  • IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
  • Protein array of 364 human recombinant protein fragments.

Linkage

Corresponding Antigen APREST83392

Physical form

Solution in phosphate buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide.

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

  • Specification Sheet

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    R41014

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Kimi Araki et al.
    Nucleic acids research, 30(19), e103-e103 (2002-10-05)
    The Cre-lox system is an important tool for genetic manipulation. To promote integrative reactions, two strategies using mutant lox sites have been developed. One is the left element/right element (LE/RE)-mutant strategy and the other is the cassette exchange strategy using
    Huseyin Tas et al.
    PloS one, 10(9), e0136963-e0136963 (2015-09-04)
    We describe an optimized system for the easy, effective, and precise modification of the Escherichia coli genome. Genome changes are introduced first through the integration of a 1.3 kbp Landing Pad consisting of a gene conferring resistance to tetracycline (tetA)
    Zhong-Wei Du et al.
    Stem cells (Dayton, Ohio), 27(5), 1032-1041 (2009-05-06)
    To circumvent the silencing effect of transgene expression in human embryonic stem cells (hESCs), we employed the Cre recombination-mediated cassette exchange strategy to target the silencing-resistant site in the genome. We have identified new loci that sustain transgene expression during

    Related Content

    AAVS1 Safe Harbor Gene Targeting

    Fluorescently tagged cell lines for drug discovery, and high content imaging analysis; lung cancer knockout, breast cancer knockout, colorectal carcinoma knockout.

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service